Not estimable in the model [BE/BA News]

posted by ElMaestro  – Denmark, 2017-03-14 12:02 (2156 d 10:14 ago) – Posting: # 17152
Views: 21,634

Hi The user,

❝ I decided to continue the topic (moreover Simon kindly directed me here).

❝ Regarding "Not estimable". Could you please share your expirience with following issue? When I use such a model: Sequence+Period+Treatment+Group+Patient(Sequence) I get "Not estimable" in the results of ABE in WNL. Model is wrong? When I delete the "group" than error dissapeares. Comments: it is BE cross over study in 3 groups and all effects are fixed.


Hmmmm... thinking loud here... In a type III model Group will have in your case up to three columns in the model matrix, but every column is equally represented by the subjects in the respective groups. Hence Group has zero df's and no effect for any level of Group can be estimated.

Try a type I model with Group before Subjects, then you'll get something that is estimable, I believe.

Pass or fail!
ElMaestro

Complete thread:

UA Flag
Activity
 Admin contact
22,485 posts in 4,710 threads, 1,603 registered users;
23 visitors (0 registered, 23 guests [including 8 identified bots]).
Forum time: 22:16 CET (Europe/Vienna)

The difference between a surrogate and a true endpoint
is like the difference between a cheque and cash.
You can get the cheque earlier but then,
of course, it might bounce.    Stephen Senn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5